MARKET

ZEAL

Zealand Pharma A/S
ZEAL
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-8.8338
16.86
11.46
813,876,564.84
Zealand Pharma Says EC Grants Marketing Authorization For Zeydovio, Long-Acting, Next-Gen GLP-2 Analog, For Treatment Of Adults With Short Bowel Syndrome
Benzinga · 11/13 15:01
Generate Biomedicines To Receive $30M Upfront, Up To $1.2B In Milestones And Tiered Royalties Under Zealand Pharma Collaboration
Benzinga · 10/13 20:34
Zealand Pharma Announces Formal Endorsement To Advance Petrelintide, Amylin Analog For Chronic Weight Management, Into Phase 3 Trials With Its Partner Roche; Initiation Planned For H2 2026
Benzinga · 04/29 17:04
Zealand Pharma Increases Share Capital By DKK 150,317 Through Issuance of 150,317 New Shares
Benzinga · 12/11/2025 21:01

Webull offers Zealand Pharma A/S stock information, including NASDAQ: ZEAL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZEAL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZEAL stock methods without spending real money on the virtual paper trading platform.